Fujifilm plans $20M U.S. facility for burgeoning interest in stem cell treatments  

4th January 2019 Uncategorised 0

A host of companies are developing regenerative treatments that lean on stem cells. Seeing an opportunity, Japan’s Fujifilm will build a U.S. stem cell manufacturing facility not only for its own efforts but also as a CDMO.

More: Fujifilm plans M U.S. facility for burgeoning interest in stem cell treatments  
Source: fierce